NEW YORK ( TheStreet) -- Shares of Dynavax Technologies Corporation (Nasdaq: DVAX) were gapping down Wednesday morning with an open price 18.5% lower than Tuesday's closing price. The stock closed at $5.09 Tuesday and opened today's trading at $4.15. The average volume for Dynavax has been 1.6 million shares per day over the past 30 days. Dynavax has a market cap of $750.5 million and is part of the health care sector and drugs industry. Shares are up 53.3% year to date as of the close of trading on Tuesday. Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious diseases. TheStreet Ratings rates Dynavax as a sell. The area that we feel has been the company's primary weakness has been its disappointing return on equity. You can view the full Dynavax Ratings Report. Get more investment ideas from our investment research center.
HOST // Robert Powell
Retirement Planning Event
More from Markets
Citigroup, Morgan Stanley and Other Banks Roiled as U.S. Yield Curve Inverts
The yield curve inverts, and bank stocks suffer.
Shaq Tells TheStreet About the Moment He Fell in Love With Papa John's
Shaq tells TheStreet that 'everyone loves pizza and pizza loves everyone' after he joins the board of Papa John's. Watch the interview.
Dow Slammed on Weak Global Manufacturing Data; Inverted Yield Curve Hits Banks
Stocks closed sharply lower Friday after Wall Street was rattled by weaker-than-expected manufacturing data in the U.S. and Europe.